Advertisement

Featured Results from ACC 2014 in NEJM Journal Watch & CardioExchange — Physician’s First Watch

Medical News |
April 1, 2014

Featured Results from ACC 2014 in NEJM Journal Watch & CardioExchange

By the NEJM Journal Watch Editors

The following studies were released at the American College of Cardiology's annual scientific session:

  • High-sensitivity cardiac troponin T may help sort out patients with chest pain who need to be admitted to the hospital. Levels under 5 ng/L had a 30-day negative predictive value of 99.6%.

  • In noncardiac surgery, use of aspirin with or without clonidine in the perioperative period didn't affect an outcome measured as a composite of death or nonfatal MI by 30 days, according to the POISE-2 investigators.

Reader Comments (2)

Dr. V Kantariya MD Physician, Family Medicine/General Practice

Dealing with Troponin Elevations- hs cTn-1 or hs cTn-T. Diagnostic Sensitivity and Specificity: Troponin 1 vs. Troponin T. Troponin T elevation predicts mortality associated with myocardial infarction (peak Troponin T >0.05ng/ml). Troponin I elevation (peak >0..5ng/ml)predictor of mortality. What about Specificity?

Winnewisser M. Juerg Physician, Internal Medicine, Wattwil Hospital, Switzertland

Interisting Study

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement